Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sputnik V 75 percent effective against Omicron: Vaccine developer

Ruchika Sharma20 Jan 2022 9:00 AM IST

Moscow: The effectiveness of the Sputnik V Covid-19 vaccine against the Omicron coronavirus variant is 75 per cent, Alexander Gintsburg, the head of...

Bharat Biotech receiving reports on wrong COVID vaccine administration in 15-18 years old

Ruchika Sharma19 Jan 2022 1:17 PM IST

Hyderabad: Bharat Biotech on Tuesday said it is receiving several reports that children in the age group of 15-18 years are being administered...

AP Medical representatives goes on strike against new labour codes, demand TA, DA

Ruchika Sharma19 Jan 2022 1:15 PM IST

Kakinada: Medical representatives, who hold allegiance to AP Medical and sales representatives union, staged demonstration near the Collectorate here...

Stempeutics bags DCGI nod for Phase 3 trial on Stempeucel for COVID patients suffering from ARDS

Ruchika Sharma19 Jan 2022 11:42 AM IST

New Delhi: Stempeutics, a group company of Manipal Education and Medical Group (MEMG), on Tuesday said it has received DCGI clearance to conduct Phase...

Lupin enters into partnership with Foncoo for China

Ruchika Sharma19 Jan 2022 11:22 AM IST

Mumbai: Global pharma major, Lupin Limited today announced that the company has entered into a partnership with Shenzhen Foncoo Pharmaceutical Co....

MTaI urges Govt to reduce GST on medical devices

Ruchika Sharma18 Jan 2022 1:06 PM IST

"We feel the customs duty for medical devices and equipment should be brought down to 0-2.5 per cent," MTaI Chairman stated.

Ex-Sanofi MD Rajaram Narayanan appointed as SeQuent Scientific MD, CEO

Ruchika Sharma18 Jan 2022 12:34 PM IST

Mumbai: SeQuent Scientific Limited has recently announced that its Board of Directors has appointed Rajaram Narayanan as Managing Director and Chief...

Strides Pharma subsidiary gets USFDA nod for Oseltamivir Phosphate for Oral Suspension

Ruchika Sharma18 Jan 2022 12:09 PM IST

Bengaluru: Strides Pharma Science Limited has recently announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited,...

CoSara Diagnostics gets CDSCO clearance for High-Risk HPV Multiplex Test

Ruchika Sharma17 Jan 2022 4:17 PM IST

Salt Lake City: Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...

Lupin, Sun Pharma recall products in US

Ruchika Sharma17 Jan 2022 12:02 PM IST

New Delhi: Leading drugmakers Sun Pharma and Lupin are recalling products in the US, the world's largest market for medicines, for different...

Glenmark Regadenoson Injection gets USFDA okay

Ruchika Sharma17 Jan 2022 11:25 AM IST

Mumbai: Drug maker, Glenmark Pharmaceuticals Inc., USA has received tentative approval by the United States Food & Drug Administration (USFDA)...

Gilead Sciences withdraws use of Zydelig for 2 types of cancer

Ruchika Sharma16 Jan 2022 11:00 AM IST

New Delhi: Gilead Sciences Inc on Friday notified the U.S. health regulator of its decision to voluntarily withdraw the use of its drug Zydelig...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok